Non β2-glycoprotein I cofactors for antiphospholipid antibodies

Lupus

Volumn 5, Issue 5, 1996, Pages 388-392

  Galli, M ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

Anti prothrombin antibodies; Antiphospholipid antibodies; Antiphospholipid syndrome; Cofactors; Lupus anticoagulants

Indexed keywords

ACTIVATED PROTEIN C; BETA2 GLYCOPROTEIN 1; KININOGEN; LIPOCORTIN 5; PHOSPHOLIPID ANTIBODY; PROTEIN S; PROTHROMBIN; THROMBOMODULIN;

ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; CLINICAL FEATURE; CONFERENCE PAPER; FETUS DEATH; HUMAN; MOLECULAR RECOGNITION; PRIORITY JOURNAL; RECURRENT ABORTION; RISK FACTOR; THROMBOCYTOPENIA; VEIN THROMBOSIS;

EID: 0029829790     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339600500511     Document Type: Conference Paper

References (42)

1. Harris EN, Gharavi AE, Hughes GRV. Antiphospholipid antibodies. Clin Rheum Dis 1985; 11:591-594.
2. Alarcon-Segovia D, Sanchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989; 16:482-488.
3. Galli M, Daldossi M, Barbui T. Anti-glycoprotein Ib/IX and IIb/IIIa antibodies in patients with antiphospholipid antibodies. Thromb Haemostas 1994; 71:571-575.
4. Stasi R, Stipa E, Masi M et al. Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura. Blood 1994; 84:4203-4208.
5. Vermylen J, Blockmans D, Spitz B, Deckmin H. Thrombosis and immune disorders. Clin Haematol 1986; 15:393-412.
6. 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87:4120-4124.
7. Galli M, Comfurius P, Maassen C et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335:1544-1547.
8. Matsuura E, Igarashi Y, Fujimoto M et al. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990; 336:177-178.
9. 2-glycoprotein I for binding of anticardiolipin antibodies to cardiolipin. Lancet 1990; 336:1952-1953.
10. 2-glycoprotein I as an antigen. J Immunol Meth 1991; 143:223-229.
11. 2-glycoprotein I in the absence of phosphohpid. Br J Haematol 1992; 82:571-574.
12. 2-glycoprotein I antigenicity induced by phospholipid binding. Thromb Haemostas 1993; 69:361-365.
13. 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994; 179:457-462.
14. 2-glycoprotein I is bound to a suitable surface. Thromb Haemostas 1995; 73:29-34.
15. Bevers EM, Galli M, Barbui T et al. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemostas 1991; 66:629-632.
16. Oosting JD, Derksen RHWM, Bobbink IWG et al. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C or protein S: an explanation for their pathogenic mechanisms. Blood 1993; 81:2618-2625.
17. 2-glycoprotein I in the expression of lupus anticoagulant activity. Blood 1994; 83:2878-2894.
18. Rao LVM, Hoang AD, Rapaport SI. Differences in the interactions of lupus anticoagulant IgG with human prothrombin and bovine prothrombin. Thromb Haemostas 1995; 73:668-674.
19. Arvieux J, Darnige L, Reber G, Bensa JC, Colomb MG. Development of an ELISA for auto antibodies to prothrombin showing their prevalence in patients with lupus anticoagulants Thromb Haemostas 1995; 74:1120-1125.
20. Galli M, Beretta GL, Daldossi M, Bevers EM, Barbui T. Characterization of the anticoagulant and immunological properties of antiprothrombin antibodies in patients with antiphospholipid antibodies. (Submitted).
21. Sugi T, McIntyre JA. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex. Blood 1995; 86:3083-3089.
22. Matsuda J, Saitoh N, Goihci K et al. Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody. Am J Hematol 1994; 47:56-58.
23. Gibson J, Nelson M, Brown R et al. Autoantibodies to thrombomodulin: development of an enzyme immunosassay and survey of their frequency in patients with the lupus anticoagulant. Thromb Haemostas 1992; 67:507-509.
24. 2-glycoprotein I in the absence of phospholipid. Importance of antigen density and bivalent binding. J Immunol 1995; 154:954-960.
25. Wu JR, Lenz BR. Phospholipid-specific conformational changes in human prothrombin upon binding to procoagulant acid lipid membranes. Thromb Haemostas 1994; 71:596-604.
26. Fleck RA, Rapaport SI, Rao LVM. Anti-prothrombin antibodies and the lupus anticoagulant. Blood 1988; 72:512-519.
27. 2-glycoprotein I. Thromb Haemostas 1992; 68:297-300.
28. 2-glycoprotein I-dependent antiphospholipid antibodies. Blood 1995; 86:617-623.
29. Bernini JC, Buchanan GR, Ashcraft J. Hypoprothrombinemia and severe hemorrhage associated with a lupus anticoagulant. J Pediatr 1993; 123:937-939.
30. Puri RN, Zhou F, Hu CJ et al. High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets. Blood 1991; 77:500-507.
31. Berard M, Sugi T, McIntyre JA et al. Prevalence and kininogen-dependence of antiphosphatidylethanolamine antibodies. Nouv Rev Fr Hematol 1995; 37 (suppl II):S69-S72.
32. Sugi T, McIntyre JA. Plasma proteins required for antiphospholipid antibody detection. Nouv Rev Fr Hematol 1995; 37 (suppl II):S49-S52.
33. Smimov MD, Triplett DA, Comp PC et al. On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies. J Clin Invest 1995; 95:309-316.
34. Smeets EF, Comfurius E, Bevers EM, Zwaal RFA. Contribution of different phospholipid classes to the prothrombin converting capacity of sonicated lipid vesicles. Thromb Res 1996; 81:419-426.
35. Rauch J, Tannenbaum M, Janoff AS. Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids. Thromb Haemostas 1989; 62:892-896.
36. Rauch J, Janoff AS. Phospholipid in the hexagonal II phase is immunogenic: evidence for immunorecognition of nonbilayer lipid phase in vivo. Proc Natl Acad Sci USA 1990; 87:4112-4114.
37. De Stefano V, Leone G, Mastrangelo S et al. Clinical manifestations and management of inherited thrombophilia: retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of Antithrombin III, Protein C, Protein S. Thromb Haemostas 1994; 72:352-358.
38. Reutelingsperger CPM, Kop JMM, Hornstra O, Hemker HC. Purification and characterization of a novel protein from bovine aorta that inhibits coagulation. Eur J Biochem 1988; 173:171-178..
39. Bohn H. Placental and pregnancy proteins. In: Lehman FG (ed) Carcinoembryonic proteins. Vol 1. Elsevier, North Holland Biomedical Press: Amsterdam, 1979; pp 289-299.
40. Reutelingsperger CPM, Hornstra G, Hemker HC. Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord. Eur J Biochem 1985; 151:625-629.
41. Rand JH, Wu X-X, Nemerson Y, Lockwood CJ. Deficiency of annexin V (placental anticoagulant protein-I) on the surface of placental villi of women with antiphospholipid antibodies and recurrent abortions. Thromb Haemostas 1993; 69:953 (abstract).
42. LaRosa L, Meroni PL, Tincani A et al. Beta-2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome. J Rheumatol 1994; 21:1678-1683.